$55.48
-1.55-2.73%
Last update: Nov 12, 1:33 PM
Diebold Nixdorf Inc
DBDNYSE
Diebold Nixdorf fell 12.5% from $65.18 to $57.04, behind the S&P 500's +11.2%. Its worst day was Jul 29 (−17.2%), and its low came Oct 30 at $55.05.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $2.75 beat the $1.68 estimate on $1.1B revenue (est. $1.1B); FY revenue guidance of $3.9B–$3.9B against the $3.9B consensus.
+4.5% · S&P 500 −1.5%
Story events cover the past 12 months · Times ET
EPS of $0.67 beat the $0.62 estimate on $891.8M revenue (est. $859.1M); FY revenue guidance of $3.9B–$3.9B against the $3.9B consensus.
−7.4% · S&P 500 +1.0%
Diebold Nixdorf shares rose 6.9%, while the S&P 500 rose 0.7%.
+6.9%, the year's best day · S&P 500 +0.7%
EPS of $1.10 beat the $1.10 estimate on $930.8M revenue (est. $925.5M); FY revenue guidance of $3.9B–$3.9B against the $3.9B consensus.
−17.2%, the year's worst day · S&P 500 −1.5%
EPS of $1.34 beat the $1.31 estimate on $994.3M revenue (est. $970.6M); FY revenue guidance of $3.9B–$3.9B against the $3.9B consensus.
−12.9% · S&P 500 +0.3%
Where it ended: a close of $57.04 on Nov 11, 2026. Up next: Q4 2026 earnings on Feb 11, 2027 (EPS est. $1.60, revenue est. $1.1B).
Nothing in the past 12 months.
All DBD dividend historyReplay the year: the line draws itself and stops at each of the 5 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for DBD and SPY from Benzinga historical bars. Not investment advice.
